Prognostic value of tumor immune biomarkers in biopsies from patients with refractory solid cancers.
Lambert T, Pobel C, Colmet-Daage L, Bigorgne A, RaubyY B, Aladro NS, Ter-MinassianN L, Kerisit M, Marabelle A, Besse B, Hollebecque A, Champiat S, Massard C, Morel D, Verlingue L, Scoazec JY.
Lambert T, et al.
Cancer Treat Res Commun. 2022;32:100611. doi: 10.1016/j.ctarc.2022.100611. Epub 2022 Jul 19.
Cancer Treat Res Commun. 2022.
PMID: 35905672
Free article.